M&A Deal Summary

Acerus Pharma Acquires Serenity

On February 28, 2022, Acerus Pharma acquired life science company Serenity for 6M USD

Acquisition Highlights
  • This is Acerus Pharma’s 1st transaction in the Life Science sector.
  • This is Acerus Pharma’s largest (disclosed) transaction.
  • This is Acerus Pharma’s 1st transaction in the United States.
  • This is Acerus Pharma’s 1st transaction in Pennsylvania.

M&A Deal Summary
Date 2022-02-28
Target Serenity
Sector Life Science
Buyer(s) Acerus Pharma
Deal Type Add-on Acquisition
Deal Value 6M USD

Target

Serenity

Milford, Pennsylvania, United States
Serenity is a specialty pharmaceutical company focused on developing therapies for diseases associated with voiding disorders. Serenity is working to develop patented pharmaceuticals with unique delivery mechanisms and formulations, to provide safe and effective treatments for voiding disorders. Serenity was founded in 2006 and is based in Milford, Pennsylvania.

Search 198,123 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Acerus Pharma

Mississauga, Ontario, Canada
Category Company
Founded 2008
Sector Life Science
Employees10
Revenue 1M CAD (2020)
DESCRIPTION

Acerus Pharma is a specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that improve patient experience, with a primary focus on the field of men’s health. Acerus Pharma commercializes its products via its own salesforce in the United States and Canada, and through a global network of licensed distributors in other territories. Acerus Pharma was founded in 2008 and is based in Mississauga, Ontario.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Pennsylvania) 1 of 1
Country (United States) 1 of 1
Year (2022) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal